Ponce, Pilar, NONE. S.

HRN: 04-43-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/20/2022
10/27/2022
IV
2.25 G
Q6
Urosepsis
Waiting Final Action 
10/29/2022
CO-AMOXICLAV 625MG (TAB)
10/29/2022
11/04/2022
PO
625mg
Q8
Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: